Doxepin FDA Link Generic

A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.

Also Known As:

Mareen; Zonalon; Aponal; Sinequan; Sinquan; Apo-Doxepin; Deptran; Desidox; Doneurin; Doxepia; Doxepin Hydrochloride; Doxepin Hydrochloride, Cis-Trans Isomer Mixture (approximately 1:5); Doxepin beta; Doxepin-RPh; Espadox; Novo-Doxepin; Prudoxin; Quitaxon; Xepin; Apo Doxepin; ApoDoxepin; Doxepin RPh; Hydrochloride, Doxepin; Novo Doxepin; 1-Propanamine, 3- dibenz(b,e)oxepin- 11(6H)- ylidene- N,N- dimethyl-

Pharmalogical Action Categories:

Antidepressive Agents, Tricyclic
Histamine Antagonists

Organic Chemicals: 133
- Ethers: 242
  - Cyclic Ethers: 12
    - Oxepins: 16
      - Doxepin: 363
Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 3-Ring Heterocyclic Compounds
    - Dibenzoxepins
      - Doxepin: 363

Doxepin Products